This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback
Trial record 1 of 250165 for:    ALL
Previous Study | Return to List | Next Study

Health Outcomes Tied to the Expansion of EITC in Single Adults

This study is not yet open for participant recruitment.
See Contacts and Locations
Verified July 2017 by Peter Muennig, Columbia University
Sponsor:
Collaborator:
MDRC
Information provided by (Responsible Party):
Peter Muennig, Columbia University
ClinicalTrials.gov Identifier:
NCT03226548
First received: July 18, 2017
Last updated: July 20, 2017
Last verified: July 2017
  Purpose
Paycheck Plus (PP) is a randomized controlled experiment (RCT) that explores the health and longevity effects associated with increasing the Earned Income Tax Credit (EITC). EITC is a national program that provides tax credits to low-income, disproportionately minority workers who file taxes. EITC is politically popular, having received bipartisan support. The EITC, along with state supplemental programs, have 7 million American families out of poverty. The investigators' preliminary data analyses show that the EITC has had large population health impacts, reversing declines in self rated health and survival among the poorest Americans.

Condition Intervention
Poverty Tax Policy Other: Paycheck Plus

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
Randomized Controlled Trial
Masking: No masking
Primary Purpose: Prevention
Official Title: The Earned Income Tax Credit (EITC) and the Health of Adults Without Dependent Children: A Randomized Controlled Trial

Further study details as provided by Peter Muennig, Columbia University:

Primary Outcome Measures:
  • Mean Score on the Patient Health Questionnaire-9 (PHQ-9) [ Time Frame: 2 Years ]
    Depression will be measured using the subject's score on the PHQ-9.


Secondary Outcome Measures:
  • Mean Total Cholesterol [ Time Frame: 2 Years ]
  • Mean Body Mass Index (BMI) [ Time Frame: 2 Years ]
  • Mean Blood Pressure (BP) [ Time Frame: 2 Years ]
  • Blood Quality of Life Score [ Time Frame: 2 Years ]
    This will be measured by the EuroQoL 5D-5L

  • Mean HbA1c [ Time Frame: 2 Years ]
  • Mean C-reactive Protein [ Time Frame: 2 Years ]
  • Prevalence of Mortality [ Time Frame: 2 Years ]

Estimated Enrollment: 4000
Anticipated Study Start Date: September 2018
Estimated Study Completion Date: November 2021
Estimated Primary Completion Date: September 2020 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Experimental
Paycheck Plus: Participants will receive four times the standard Earned Income Tax Credit after filing their annual taxes
Other: Paycheck Plus
A four-fold increase in the Earned Income Tax Credit
No Intervention: Control
Control participants will receive the standard Earned Income Tax Credit after filing their annual taxes

Detailed Description:
Poverty disproportionately impacts minority and rural populations and is very strongly correlated with poor health over the life cycle, and has been hypothesized to lead to a shorter, less healthy aging process. Poverty is associated with a greater burden of disease than smoking and obesity combined and accounts for the bulk of health disparities by race. It is widely believed that an antipoverty policy, such as Earned Income Tax Credit (EITC), could improve healthy aging among working-age low-income adults over the life cycle. It does so by increasing material hardship and psychological stress, two risk factors that are strongly correlated with biological markers of premature aging (e.g., shorter telomeres, higher cholesterol levels, and higher blood pressure).
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. a US resident
  2. Filed taxes
  3. Earned <$30,000 in the previous year
  4. Aged 21-64
  5. Have a Social Security number

Exclusion Criteria:

  1. Eligible for Supplemental Security Income or Social Security Disability Insurance
  2. Married
  3. Have dependent children
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT03226548

Contacts
Contact: Peter A Muennig, MD 212-342-3170 pm124@columbia.edu
Contact: Heidi Allen, PhD 212-851-2242 ha2332@columbia.edu

Locations
United States, Georgia
Westat Not yet recruiting
Atlanta, Georgia, United States, 30303
Sponsors and Collaborators
Columbia University
MDRC
Investigators
Principal Investigator: Peter Muennig, MD Columbia University
  More Information

Responsible Party: Peter Muennig, Professor of Health Policy and Management, Columbia University
ClinicalTrials.gov Identifier: NCT03226548     History of Changes
Other Study ID Numbers: AAAQ9663 (ADD-ON)
Study First Received: July 18, 2017
Last Updated: July 20, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: To protect participant privacy we cannot share our data

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Peter Muennig, Columbia University:
Earned Income Tax Credit (EITC)
Tax Credit
Paycheck Plus

ClinicalTrials.gov processed this record on July 21, 2017